Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Nordic Nanovector launches US Phase 2b trial for Betalutin in follicular lymphoma Nordic Nanovector, a Norwegian biopharmaceutical company, has commenced the first clinical site in the United States for its… bypharmanewsdailyOctober 28, 2018